Profil
Patricia Zilliox currently works at Eyevensys SAS, as President & Chief Executive Officer and Acticor Biotech SAS, as Independent Director from 2023.
Dr. Zilliox also formerly worked at Foundation Fighting Blindness Clinical Research Institute, as Chief Executive Officer, Alcon Laboratories, Inc., as Senior Director-Clinical Pharma, and The Foundation Fighting Blindness, Inc., as Chief Drug Development Officer.
Aktive Positionen von Patricia Zilliox
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTICOR BIOTECH | Direktor/Vorstandsmitglied | 26.01.2023 |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Vorstandsvorsitzender | 12.12.2017 |
Ehemalige bekannte Positionen von Patricia Zilliox
| Unternehmen | Position | Ende |
|---|---|---|
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 01.01.2011 |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Vorstandsvorsitzender | - |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Provides investment services | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Develops non-viral gene therapy process for the treatment of ocular illnesses | Commercial Services |
Acticor Biotech SAS
Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
















